Categories
Coronavirus Energy Industry Analysis

Clostridium Difficile Infection Treatment Market With CAGR 9% in 2019 to 2029| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

The critical need for non-antibiotic alternatives for prophylaxis and treatment of Clostridium difficile infections is shaping the market landscape of Clostridium difficile infection treatment. The global Clostridium difficile infection treatment market was valued US$ 840 Mn in 2018 and will exhibit a promising CAGR during the forecast period (2019 – 2029).

Key factors such as easy accessibility of diagnostic tests and accessibility of generic antimicrobial drugs (metronidazole and Vancomycin) continue to fuel the Clostridium difficile infection treatment market growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15775

Company Profiles 

  • Merck & Co., Inc
  • Baxter International Inc.
  • Sanofi S.A.
  • Pfizer Inc.
  • Novartis AG
  • Astellas Pharma
  • Eli LilIy & Company
  • AstraZeneca
  • Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.)
  • Mylan N.V.

Increasing incidence of Clostridium difficile infection demands for strengthening R&D program, thereby propelling growth of the Clostridium difficile infection treatment market. In 2017, Actelion conducted phase III clinical trial for comparing cadazolid with vancomycin for the treatment of Clostridium difficile associated diarrhea.

As per Center for Disease Control & Prevention (CDC) 2015, prevalence of C. difficile infection is increasing and is most common healthcare-associated infection among adults.

Key Takeaways – Clostridium difficile Infection Treatment Market Study

  • Clostridium difficile infection treatment market is characterized as mature market. Whereas, introduction of new class of therapeutic agents (such as monoclonal antibodies) for treatment is expected to generate market growth opportunities.
  • Metronidazole, Fidaxomicin, and Vancomycin are most commonly prescribed medication. Although, prescription pattern is diverse across the world attributing to variation in the occurrence of Clostridium difficile infection after treatment with each class of drug.
  • In the U.S., metronidazole is suggested as a first line drug for Clostridium difficile treatment followed by the combination of vancomycin and fidaxomicin. In Western nations such as the U.S., Canada, and few European nations, utilization of anti-infection agents has flooded for over two decades, thus increasing the incidence of Clostridium difficile infection in these regions.
  • The sale of fidaxomicin, vancomycin, and metronidazole through retail pharmacies and mail order pharmacies is increasingly contributing to the global Clostridium difficile treatment market growth.
  • Uncontrolled utilization of broad range anti-infection drugs and absence of consistent cleanliness standards at clinics are increasing the rate of prevalence of Clostridium difficile infection.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/15775

Launch of monoclonal antibody drugs for treatment of Clostridium difficile infection and counteractive action for recurrent Clostridium difficile infection has shifted the focus from antibiotics to recently approved therapeutic class of drugs. This new class of drugs represents a breakthrough and will create an extreme challenge for conventional antibiotic medicines for Clostridium difficile infection.

Strategic Partnerships – Winning Imperatives for Market Leaders

The key players are focusing on new product launches, collaborations, territorial expansion, mergers, and acquisitions to increase share in the market. Mergers and acquisitions are helping these players to enhance existing product portfolio and topographical reach. For example, to fortify their pharmaceutical business, Johnson & Johnson acquired Actelion Ltd, enhancing the product portfolio for Clostridium difficile infection treatment.

To increase the market revenue, Astellas Pharma Inc. launched Dafclir Tablets 200 mg for the treatment of infectious enteritis (susceptible strains: fidaxomicin susceptible Clostridium difficile (CD)2) in Japan. To strengthen its product portfolio, USFDA granted acceptance for review of New Drug Application for DIFICID (fidaxomicin) for oral suspension in pediatric patients.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15775

More Valuable Insights on Clostridium difficile Infection Treatment Market

Persistence Market Research offers a unique perspective and actionable insights on Clostridium difficile Infection treatment in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029.

The global Clostridium difficile infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

The study provides compelling insights on Clostridium difficile infection treatment market on basis of drug type (Metronidazole, Vancomycin, Fidaxomicin), route of administration (oral, injectable) and distribution channel (hospital pharmacies, retail pharmacies, mail order pharmacies) across five major regions.

Categories
Coronavirus Energy Industry Analysis

Dysphagia Management Market With CAGR 6% in 2019 to 2029| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

The new report by Persistence Market Research (PMR) unveils that the worldwide revenue of dysphagia management market to reach US$ ~3.5 Bn, by the end of 2019. It is projected that the business sector for dysphagia management is expected to grow at a healthy CAGR between 2019 and 2029, according to PMR’s research report.

Expanding presence of managed care institutions, particularly in developed economies, is fueling the demand for neglected treatments such as dysphagia management. For instance, implementation of Affordable Care Act in the U.S. has helped in successfully increasing insurance coverage because of which an increasing number of people are coming under the net of dysphagia management.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12988

Company Profiles:

  • Eisai Co. Ltd.
  • Becton, Dickinson and Company (BD)
  • AstraZeneca Plc.
  • Cipla Limited
  • Nestlé (Nestlé Health Science)
  • Kent Corporation (Kent Precision Foods Group, Inc.)
  • Danone (Nutricia Advanced Medical Nutrition)
  • Cook Group (Cook Medical Inc.)

Increasing Number of Local Players Adding to the Competition in Dysphagia Management Landscape

Growing prevalence and rising demand for nasogastric tube and PEG tubes in primary dysphagia management have created an opportunity for local players to come with dysphagia management products at competitive rates. Apart from global market players such as Cook Medical Incorporation and Becton, Dickinson and Company, there are several other local players in the regional dysphagia management market across the globe that are catering to the local market.

For example, Dr. Goyal Medical Private Limited, OR Surgicals, NeoDevices, Inc and other small players are also participating in the dysphagia management market.

According to the PMR report, in distribution channel, hospital pharmacies will dominate the supply side in the dysphagia management market by the end of 2019. Following hospital pharmacies, retail pharmacies are next expected to harness maximum share in the forecast period of 2019-2029. This is due to the growing demand for dysphagia management products avenues in developed and emerging countries.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12988

A marked shift towards generic and OTC formulations from branded products has been noticed, owing to expiry of majority of blockbuster drugs in the dysphagia management market. Ease of manufacturing, availability of raw materials at low prices, and lower costs aiding the rapid market influx of generic drugs in lower income nations are creating growth opportunities for the dysphagia management market.

Opportunities Reside in Better Patient Compliance

According to the PMR study, Kent Precision Food Groups Inc., has setup guidelines for dysphagia diet, which state different levels of diet depending on the severity of the diseased state. These guidelines help the patient as well as the healthcare providers to have a better understanding of food selection in dysphagia management.

Major companies in the dysphagia management sector are putting efforts to meet the need of patients and healthcare personnel to get a drift in the dysphagia management market. Improving patient compliance is directly related to making diets more palatable. Companies are expected to perform better on devising innovations in taste masking.

This could lead to better patient compliance among pediatric and geriatric groups needing proper dysphagia management. Development of orodispersible tablets (ODTs) that can dissolve or disintegrate rapidly in the oral cavity could help in generation of higher revenues for players in the dysphagia management market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12988

Other advantages of ODTs are no water is needed, no chewing is needed, improved stability, allows high drug loading, cost-effective and adaptable to existing processing and packaging machinery. Complying with these factors creates a tremendous growth opportunity for the competitors in dysphagia management sector.

Further, acceptance of such drugs among patient groups is also high due to cost effectiveness of the type of medication. Companies operating in dysphagia management are thus expected to largely benefit from development of palatable and cost-effective ODTs. PMR’s analysis also demonstrates groundbreaking views on the business sector of the dysphagia management market along with insights on key business approaches and policies by competitors in the dysphagia management business.

Categories
Coronavirus Energy Industry Analysis

Breast Implant Market With CAGR 4.2% in 2024| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

Worldwide sales of breast implants is expected to reach ~ US$ 1.8 Bn by the end of 2019 and is forecasted to reach ~ US$ 1.7 Bn by the end of 2029, unveils the new research study by Persistence Market Research (PMR). According to the report, the breast implants market is estimated to grow by ~3% Y-O-Y by the end of 2020, primarily influenced by the recent advancements in the breast implants market.

According to the report, greater emphasis on physical appearance of the breasts and rise in global per capita disposable income of women have led to more number of women undergoing breast implants procedures globally. Also, manufacturers of breast implants are focusing on introducing wide range of breast implants in terms of sizes, shapes, and texture, which is expected to upsurge the growth of the global breast implants market over the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10972

Company Profiles

  • Allergan, Plc (Actavis Plc)
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Combined Breast Augmentation to Create Scope for the Market Growth

Breast augmentation procedures in combination with breast lifting have received much attention among women in recent years to enhance the appearance of their breasts in terms of shape and size particularly those who are concerned with deflated or sagging breast appearance. While a breast lift procedure will elevate and reshape breasts, breast implants will add volume to their breasts.

Also combined procedural cost is less when compared to the individual procedure leading to more number of women opting for both procedures at one time. These factors are anticipated to aid the growth of the breast implants market over the forecast period.

Strong Distribution Network to Drive the Breast Implants Market

Strong distribution network is one of the prime factors responsible for the growth of the global breast implants market. Various major implants manufacturers are undergoing distribution agreements in order to make their products available resulting in deep penetration of aesthetic services across low income countries.

Thus, easier availability of products and increasing demand for breast implants products globally, is contributing to the overall growth of the breast implants market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10972

Greater Emphasis on Physical Appearance is a Factor Fueling the Market Growth

Greater emphasis on aesthetic appearance is the main factor fueling revenue growth of the breast implants market globally. A large number of women are conscious about the physical appearance of their breasts leading to increasing number of breast augmentation procedures in developed countries such as North America and Europe.

However, some of the most common reasons for breast augmentation procedures include changing the breast size, restoring natural appearance of breasts, and correcting capsular contracture.

Also, women are increasingly spending on cosmetic surgical procedures to enhance their physical appearance and the number is expected to rise significantly over the next few years.

According to the U.S.-based National Institute of Aging and American Academy of Plastic Surgeons, a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, are increasingly resorting to advanced aesthetic services including breast implants thus, creating sufficient traction for manufacturers in the breast implants market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/10972

Composite Breast Augmentation to Boost Patient Base for Breast Implants

Composite breast augmentation combines the ability of a breast implants to provide increased volume of breasts with reshaping capabilities offered by fat grafting technique. The technology together provides more versatility, especially in women who are more concerned about animation deformities and patients who are athletic. The technique is expected to have a major influence on the breast implants market globally over the next few years.

Categories
Coronavirus Energy Industry Analysis

Urinary Catheters Market With CAGR 4.1% in 2021| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

Global revenue of urinary catheters reached ~ 1.5 billion in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report, the urinary catheters market is estimated to grow by ~4% YOY in 2019, primarily attributed to ease of use, cost effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favored for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc.
  • Hollister Incorporate
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity.

Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3268

The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery.

Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3268

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters.

In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market.

A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~4%. Accounting for ~23% share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.

Categories
Coronavirus Energy Industry Analysis

Triple Negative Breast Cancer Treatment Market With CAGR 4.7% in 2026| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

Ongoing advancements in cancer research continue to lead to the introduction of newer and better treatment options including drug therapies. The provision of newer drugs and treatments is expected to improve the diagnostic and treatment rate for triple-negative breast cancer.

Some of the recent clinical efforts are being targeted at the molecular level characterization of triple-negative breast cancer across emerging therapeutic targets such as epigenetic proteins, PARP1, androgen receptors, receptor and non-receptor tyrosine kinases, and immune checkpoints.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14305

Company Profiles

  • AstraZeneca PLC
  • Johnson & Johnson Services, Inc.
  • Pfizer, Inc.
  • F. Hoffman – La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Mylan N.V.
  • Eli Lilly and Company
  • Celgene Corporation
  • Sanofi S.A.
  • Others.

These initiatives are anticipated to boost revenue growth of the triple-negative breast cancer treatment market. In a new research study, Persistence Market Research estimates the global triple-negative breast cancer treatment market revenue to cross US$ 720 Mn by 2026 from an estimated valuation of just under US$ 505 Mn in 2018. This is indicative of a CAGR of 4.7% during the period 2018 to 2026.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14305

Development of generics is another key opportunity area in the triple-negative breast cancer treatment market. With the rapidly expanding number of cancer cases across the world, there is a need for effective cancer management, including the provision of better and more efficient drugs.

Developing economies are faced with challenges on several fronts including paucity of funds and lack of proper treatment options, calling for more innovative approaches to affordable healthcare. The availability of biosimilars and affordable generic anti-cancer drugs in developing regions is expected to significantly reduce the burden of cancer care.

A projected cost reduction to the tune of more than 30% – 40% and extended use of generic drugs is expected to reduce overall cancer treatment costs, thereby increasing the treatment rate for triple-negative breast cancer. This is further anticipated to create lucrative growth opportunities in the global triple-negative breast cancer treatment market.

Advances in Cancer Treatment and Introduction of Innovative Cancer Treatment Drugs to Boost Revenue Growth of the Triple-Negative Breast Cancer Treatment Market

Breast cancer is one of the most common types of cancer in women, and over the years, pharmaceutical and life sciences companies have been conducting advanced research and development activities to devise newer treatment options and drugs to treat breast cancer.

Several new drug formulations are currently in the pipeline in different stages of clinical development and this is expected to bode well for the triple-negative breast cancer treatment market. Innovation in oncology therapeutics has shifted focus towards an outcome based approach to cancer care, with an increasing emphasis on combination drugs and newer therapeutic modalities.

This is further likely to put the global triple-negative breast cancer treatment market on a positive growth trajectory in the coming years.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14305

Combination Therapy and Advancements in Nano Medicine Research Trending the Triple-Negative Breast Cancer Treatment Market

One of the biggest trends being observed in the global market for triple-negative breast cancer treatment is the shift towards combination therapy. Companies in the global triple-negative breast cancer treatment market are conducting clinical trials for combination therapies by collaborating with other players in the market.

Combination therapies are the latest innovation in the field of oncology and the combination of therapeutic drugs with chemotherapy is said to be an effective protocol for the treatment of triple-negative breast cancer.

Another huge trend in the triple-negative breast cancer treatment market is the emergence of nanotechnology as an efficient tool in the clinical management of critical diseases such as triple-negative breast cancer. It has been observed that the combination of gold nanoparticles and folic acid results in higher cell entry rate in both in-vitro and in-vivo models, indicative of the fact that folate receptors are effective targeted therapies for the treatment of triple-negative breast cancer.

Nanoparticles facilitate systematic and efficient delivery of drugs and agents to the site of the tumor. Advanced R&D in nanotechnology and nano medicine is one of the top trends likely to impact the global triple-negative breast cancer treatment market in the years to come.

Categories
Coronavirus Energy Industry Analysis

Infrared Thermometers Market With CAGR 8.5% in 2026| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

Technical enhancements have introduced, infrared thermometer, which is capable of measuring the radiation emitted by a body, or an object. These thermometers are used for measuring ear, forehead etc. A new research report introduced by the team of Persistence Market Research, involves analysis of global infrared thermometer market. The report, titled ‘Infrared Thermometer Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026’ is based on future market forecast and factors influencing the market growth.

The outcomes of this exhaustive research process reveals that the global infrared thermometer market is expected to reach a market value of over US$ 1 Bn by the end of 2026, growing at a CAGR of 8.5% during the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10079

Company Profile

  • Welch Allyn – A Hill-Rom Inc. Company
  • Exergen
  • Geratherm Medical AG
  • Thermomedics, Inc. (A subsidiary of PositiveID Corporation)
  • Microlife Corporation
  • PAUL HARTMANN AG
  • BPL Medical Technologies
  • Contec Medical Systems Co., Ltd.
  • Cardinal Health (Medtronic)
  • OMRON Corporation
  • Braun GmbH

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10079

Infrared Thermometers Market: Overview

The global infrared thermometers market witnesses the maximum impact of increasing investments on the healthcare industry and also the various technological advancements that are taking place. This has given a birth to the infrared thermometer device and its market, which is taken ahead by the capabilities of the device. Infrared thermometers are said to provide more accurate results than the conventional thermometers.

The market is expected to gain high popularity in the coming years as more and more people will depend on the technology. It has found its application in areas like medical and veterinary industry, among which the application is currently higher in medical sector.

According to the research report, medical industry is expected to hold a market value of over US$ 620 Mn by the end of 2026. However, the future shows proliferating demand from the veterinary sector which is expected to grow at a CAGR of 8.8% during the forecast period. The market also includes different types of thermometers like forehead, ear and multifunctional.

Among these, larger part of the market is covered with the demand for forehead thermometers. It is said to be safer as compared to ear thermometers. Though forehead thermometer has high cost as compared to ear and multifunction thermometer, still people adopt forehead thermometer due to its accuracy and low rate of infection.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/10079

Infrared Thermometers Market: Competitive Landscape

The report covers a brief view of all the leading manufacturers for infrared thermometers. In the medical sector, leading providers of infrared thermometers are Braun, Contec, Omron, Hartmann, Microlife, Vivehealth etc. In the veterinary sector, the leading players are Bioseb, Mediaid, iSnow Med, Greatfarm etc. The research report has briefly depicted the market presence of such companies in the coming years and also their marketing strategies. The leading companies that are a part of tier 1, has contributed a market value of over US$ 380 Mn in 2017, whereas tier 2 companies are lagging behind and have contributed only 49% revenue in the global market.

Co-commercialization and distribution agreements are the common marketing and distribution strategies adopted by these key players in the global Infrared Thermometers market. The coming years will showcase new strategies adopted by the companies amid intensified competition.

Categories
Coronavirus Energy Industry Analysis

Acne Treatment Market With CAGR 4.6% in 2025| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication.

Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate-to-severe acne issues.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/5279

Company Profiles

  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Cutera, Inc.
  • Stiefel Laboratories Inc.
  • Galderma S.A.
  • Valeant Pharmaceutical International, Inc.
  • Verilux, Inc.
  • Johnson and Johnson
  • Syneron Medical Ltd
  • Allergan plc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5279

According to the PMR study, the global acne treatment market was pegged at US$ 4,920 Mn in 2016. This market is expected to reach US$ 7,348 Mn by the end of 2025, reflecting a CAGR of 4.6% over the forecast period (2017– 2025).

Drug makers are implementing better testing methods. Many of the active ingredients for manufacturing acne treatment medicines are used only if they are clinically evidenced and have satisfactory documented outcomes. Alma Lasers Ltd., Lumenis Ltd., Cutera, Inc, Stiefel Laboratories Inc., Galderma S.A., Verilux, Inc., Valeant Pharmaceutical International, Inc. , Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Allergan Plc., and Syneron Medical Ltd are some of top medical companies that operate in the global acne treatment market.

Many of these market players are actively focusing on expanding distribution base to emerging countries in order to improve their overall market presence. As a matter of fact, growing medical tourism in developing countries is expected to create potential market opportunities in the near future.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/5279

PMR report titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025” further reveals that the quest to look youthful from the baby boomer generation  coupled with growing preference for minimally invasive procedures and high adoption rate of prescription drugs are major factors driving the global acne market. Amongst regions, demand for acne treatment products is expected to remain high in the regions such North America and Asia pacific (APAC).

The market for acne treatment in North America is estimated to exceed a valuation of US$ 3,206 Mn towards the end of assessment period. By 2017-end, the region is expected to account for around 43.2% revenue share of the global market. Meanwhile, the market in APAC is set to expand at a CAGR of 4.8%, to reach US$ 1,718.0 Mn over the forecast period.

Key Insights of the Report Include:

  • In recent years, retinoid therapy has come up as an effective treatment module for acne. Therefore, retinoid therapy is expected to account for the largest value share of the market during the forecast period.
  • In 2017 and beyond, prevalence of inflammatory acne is anticipated to remain relatively high as compared non-Inflammatory acne.
  • By treatment modality, oral segment is estimated to account for 37.4% revenue share of the global acne treatment market by 2017 end
Categories
Coronavirus Energy Industry Analysis

Ostomy Care Accessories Market With CAGR 6.8% in 2019 to 2029| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

Recent advancements in ostomy care accessories have transformed them into small and portable wearable devices, improving standards of clinical care.

For instance, Ostom-iAlert Sensor, a clipped device from 11 Health Technologies Limited, uses a flexible sensor that provides a signal when the bag is full, through a notification on a smartphone.

Moreover, rising prevalence of gastrointestinal diseases, increasing ostomy surgeries of the bowel, and technological innovations are major factors driving the growth of the ostomy care accessories market. Rising awareness initiatives about ostomy through campaigns are anticipated to strengthen interest in developing economies, thereby boosting the growth of the global ostomy care accessories market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3200

Company Profiles

  • Coloplast A/S
  • Conva Tec Inc
  • Hollister Inc
  • EuroMed Inc (Scapa Group plc)
  • 3M Company
  • Smith & Nephew
  • FNC Medical
  • Nu-Hope Laboratories, Inc
  • Marlen Manufacturing & Development
  • Torbot Group Inc
  • Cymed Ostomy Co

Key Takeaways of Ostomy Care Accessories Market Study

  • Demand for skin protection and skin barrier types of products is expected to gain traction during the forecast period, owing to the wide usage of these products as a remedy and prevention of peristomal skin complications.
  • Demand for skin-friendly and long wear time seals is constantly increasing across various end-use industries, due to which, the sealing segment is expected to contribute three-fourth market share in the ostomy care accessories market.
  • Preference for homecare settings is expected to increase significantly, owing to the availability of trained nurses and reduced emergency visits to hospitals.
  • Rise in prevalence of inflammatory bowel diseases, increasing number of ostomy procedures, and growing usage of ostomy care accessories contributed to the dominance of Europe in the global ostomy care accessories market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3200

“Technological innovations focused on reducing skin contamination and economic burden, are trending among manufacturers offering ostomy care accessories, which is expected to significantly benefit the market”, says a PMR analyst.

Product Launch – Key Strategic Focus of Ostomy Care Accessories Market Players

The ostomy care accessories market is characterized as a fragmented market. Some of the major players in the market are Coloplast Corp., Convatec, Inc., 3M, and Hollister Incorporated. Launch of technologically-advanced products is the key strategy being followed by these market players.  For instance, in 2017, Natura Convex Cut-to-Fit, launched by ConvaTech, Inc., allows easy switching to different types of pouches. Furthermore, easy application and easy cleaning of pouches result in less skin irritation to its users.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3200

More Valuable Insights on Ostomy Care Accessories Market

Persistence Market Research brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global ostomy care accessories market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

 The study provides compelling insights on the ostomy care accessories market, on the basis of product type (belt tapes adhesives, skin protection and skin barriers, irrigation sets & sleeves, convex inserts, and stoma caps), application (sealing, drainage, cleansing, and lubrication), and end user (hospitals, ambulatory surgical centers, and home care settings), across five major regions.

Categories
Coronavirus Energy Industry Analysis

Orthopedic Veterinary Implants Market With CAGR 9% in 2026| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

A recent report by Grey2K USA suggests that more than 14,000 injuries were reported at Greyhound racing in the U.S. between 2008 and 2016. These injuries mainly included broken legs, crushed skulls, seizures, paralysis, and broken backs. According to the American Veterinary Medical Association (AVMA), the percent of dogs and cats owned by households is 36.5% and 30.4%, respectively.

While this clearly depicts the increasing need for medical services and treatment for pets, the demand for orthopedic veterinary implants is set to see remarkable rise in the near future. Increasing focus on pet health insurance is also identified as an important factor driving the market for orthopedic veterinary implants. The global orthopedic veterinary implants market will exhibit a robust CAGR of over 8% during the forecast period (2019 – 2029).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/22939

Company Profiles

  • Vet Implants
  • scil animal care company GmbH
  • KYON Pharma, Inc.
  • Everost Inc.
  • BioMedtrix, LLC
  • Integra LifeSciences
  • RITA LEIBINGER MEDICAL GmbH & Co. KG
  • B. Braun Melsungen AG
  • DePuy Synthes (Sub. Johnson & Johnson Services, Inc.)
  • Intrauma S.p.A.
  • Surgical Holdings
  • Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG

Key Takeaways – Orthopedic Veterinary Implants Market Study

  • Accounting for over a fourth of market value shares, tibial plateau levelling osteotomy (TPLO) implants will remain the most preferred product type owing to their ability to stabilize the stifle joint after rupture of cranial cruciate ligament.
  • Trauma fixations with the application of intramedullary nails, bone plates, and bone screws are extensively used for the treatment of bone fractures.
  • Increased availability of veterinary practitioners, rise in surgical procedures, and heightened number of injuries in pets are factors expected to increase the number of visits to pet clinics and hospitals.
  • North America is expected to be significant revenue generator in the orthopedic veterinary implants market owing to increase in number of surgical procedures arising from obesity-related diseases such as arthritis and sports-related dislocation of hips and bones.
  • Significant product launches are boosting the orthopedic veterinary implants market growth.
    • For instance, in October 2019, Veterinary Orthopedic Implants launched HyProtect antimicrobial coated implants.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/22939

Innovative product specifications and rise in pet care expenditure for surgical procedures are significantly favoring market growth and is expected to provide lucrative opportunities to manufacturers during the forecast period.

Strategic Partnerships – Winning Imperative for Market Participants

Manufacturers in emerging countries are focusing on strategic collaboration or alliance with regional players as well as local distributors to increase their footprint. For example, BioMedtrix collaborated with Laboratorios Macrimasa-Vet in January 2019 for distribution of its TPLO Curve, Universal Hip (including Micro & Nano Hip), I-Loc IM Fixator in Spain.

In March 2016, DePuy Synthes (part of the Johnson & Johnson) entered into an exclusive strategic alliance with Value Stream Partners, LLC to design, develop and implement programs for hip and knee replacements.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/22939

Know More About the Report

Persistence Market Research offers a unique perspective and actionable insights on orthopedic veterinary implants in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029.

The global orthopedic veterinary implants market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

The study provides compelling insights on orthopedic veterinary implants market on basis of product type (total knee replacement, total hip replacement, trauma fixations, tibial tuberosity advancement implants, tibial plateau leveling osteotomy implants, advanced locking plate system, total elbow replacement), End User (veterinary hospitals, veterinary clinics) and across five major regions.

Categories
Coronavirus Energy Industry Analysis

Sleep Aids Market With CAGR 5% in 2019 to 2029| Analysis, Revenue, Price, Market Share, Growth Rate, Forecast

market-research-report

A sizeable patient pool has been opting for various alternative therapies for sleep management, including nonprescription drugs, prescription drugs, and sleep aid devices. Widespread availability and launch of sleep aid products to treat sleep disorders are the factors for commercial success of the sleep aids market.

A new study of Persistence Market Research (PMR) suggests that global sleep aids market revenues exceeded US$ 23 Bn in 2018 and will exhibit a promising CAGR during the forecast period (2019 – 2029).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/2832

Company Profiles

  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Drive DeVilbiss Healthcare LLC
  • GlaxoSmithKline Plc.
  • Fisher & Paykel Healthcare Limited
  • Sanofi SA
  • Pfizer Inc

As per the recent report of National Healthy Sleep Awareness Project, increasing pervasiveness of obstructive sleep apnea affected 25 million adults in the U.S. alone. Nearly 69% of analyzed obstructive sleep apnea patients were utilizing continuous positive aviation route pressure (CPAP)/AutoPAP machine and 23% were utilizing Bilevel PAP machine.

Key Takeaways – Sleep Aids Market Study

  • The sleep aids market is characterized as an emerging market. Increase in obese population, surge in prevalence of sleep disorders, changing lifestyles, distressing work issues, and increasing intake of alcohol, and caffeine are the key factors fostering market growth.
  • Factors such as growing incidences of sleep apnea, government initiatives for awareness of ill effects of sleep disorders, increasing adoption rate of sleep aid services among obese population, and favorable reimbursement policies are contributing to growth of the North America sleep aids market.
  • Rising prevalence of insomnia is increasing the demand for sleep aids devices.
  • Additional benefits such as managing back pain, lower stress level, and improving quality of sleep are increasing demand for mattresses and pillows in the sleep aids market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/2832

Drugs and devices have a collective role to play in effective management of sleep disorders, with better clinical outcomes. PMR’s report states that over 85% of patients remain undiagnosed of such disorders, exhibiting the need of proper diagnosis and treatment options.

New Product Launches to Gain Competitive Advantage

The key players of the sleep aids market are focusing on product development and launches to increase their growth prospects.  Increasing investment for R&D of products to fulfill demands from targeted patient population is the key strategy of sleep aid market players. Giants in the sleep aids market are focusing to enhance geographical reach for existing and new products.

On January 8, 2019, Oventus Medical Ltd. introduced its nylon-made O2Vent Optima sleep aids device for the treatment of sleep apnea in Australia. Optima sleep aids device is an altered 3D-printed nylon oral apparatus that advances the jaw forward to open the aviation route and improves the viability of oral machine treatment.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/2832

Want to Explore the Report Inclusions?

Persistence Market Research offers a unique perspective and actionable insights on sleep aids in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029. The global sleep aids market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

The study provides compelling insights on sleep aids market on basis of product type (drugs, devices, others), indication (insomnia, sleep deprivation, narcolepsy, sleep apnea, others) and distribution channel (hospital pharmacies, retail pharmacies, e-commerce, drug stores, others) across five major regions.